The FDA knows that pharmacies, patients, and prescribers are having difficulties with the modified iPLEDGE program, including issues with website logins and call center wait times. If you do not have access to your account on the website, contact the iPLEDGE call center at 866-495-0654. FDA has issued a CDER statement requesting proposals for solutions from isotretinoin, manufacturers, pharmacies and dermatology organizations. NCPA is working with the FDA and the iPLEDGE vendor to address this situation with a temporary solution so patients will have continued access to their prescriptions and will communicate any updates via qAM as soon as possible.
NCPA
